Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Rebecca Law, David Lewis, Daniel Hain, Rachel Daut, Melissa P. DelBello, Jean A. Frazier, Jeffrey H. Newcorn, Erika Nurmi, Elizabeth S. Cogan, Susanne Wagner, Holly Johnson & Jerry Lanchbury. (2022) Characterisation of seven medications approved for attention-deficit/hyperactivity disorder using in vitro models of hepatic metabolism. Xenobiotica 52:7, pages 676-686.
Read now
Read now
Ann C. Childress, Nathalie Beltran, Carl Supnet & Margaret D. Weiss. (2021) Reviewing the role of emerging therapies in the ADHD armamentarium. Expert Opinion on Emerging Drugs 26:1, pages 1-16.
Read now
Read now
Chungping Yu. (2020) Metabolism and in vitro drug–drug interaction assessment of viloxazine. Xenobiotica 50:11, pages 1285-1300.
Read now
Read now
H. Kamimura, Y. Enjoji, H. Sasaki, R. Kawai, H. Kaniwa, K. Niigata & S. Kageyama. (1987) Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats. Xenobiotica 17:6, pages 645-658.
Read now
Read now
H. Kamimura, H. Sasaki & S. Kawamura. (1985) Metabolism of amosulalol hydrochloride in man: Quantitative comparison with laboratory animals. Xenobiotica 15:5, pages 413-420.
Read now
Read now
A. J. Hutt, G. E. Navas & A. H. Beckett. (1982) Metabolic oxidation of desmethylchlorimipramine in vitro by 9000 g rabbit-liver preparations. Xenobiotica 12:10, pages 645-655.
Read now
Read now
Peter Jenner & Bernard Testa. (1978) Novel Pathways in Drug Metabolism. Xenobiotica 8:1, pages 1-25.
Read now
Read now
David E. Case. (1975) Incorporation into Endogenous Metabolic Pathways of Small Fragments Derived from I.C.I. 58,834 (Viloxazine). Xenobiotica 5:3, pages 133-143.
Read now
Read now
David E. Case, Hilary Illston, Peter R. Reeves, Brian Shuker & Peter Simons. (1975) The Disposition and Metabolism of LCI. 58,834 (ViloxazJne) in Animals. Xenobiotica 5:2, pages 83-111.
Read now
Read now
Articles from other publishers (28)
Alexander A. Spasov, Igor N. Iezhitsa, Pavel M. Vassiliev, Alexander A. Ozerov & Renu AgarwalAlexander A. Spasov, Igor N. Iezhitsa, Pavel M. Vassiliev, Alexander A. Ozerov & Renu Agarwal. 2022. Pharmacology of Drug Stereoisomers. Pharmacology of Drug Stereoisomers
75
192
.
Robert L. Findling, Shawn A. Candler, Azmi F. Nasser, Stefan Schwabe, Chungping Yu, Jennie Garcia-Olivares, Welton O’Neal & Jeffrey H. Newcorn. (2021) Viloxazine in the Management of CNS Disorders: A Historical Overview and Current Status. CNS Drugs 35:6, pages 643-653.
Crossref
Crossref
Michele Protti, Roberto Mandrioli, Camilla Marasca, Andrea Cavalli, Alessandro Serretti & Laura Mercolini. (2020) New‐generation, non‐SSRI antidepressants: Drug‐drug interactions and therapeutic drug monitoring. Part 2: NaSSAs, NRIs, SNDRIs, MASSAs, NDRIs, and others. Medicinal Research Reviews 40:5, pages 1794-1832.
Crossref
Crossref
Georgios Schoretsanitis, Jose de Leon, Chin B. Eap, John M. Kane & Michael Paulzen. (2019) Clinically Significant Drug–Drug Interactions with Agents for Attention-Deficit/Hyperactivity Disorder. CNS Drugs 33:12, pages 1201-1222.
Crossref
Crossref
Gavin A. Whitlock, Mark D. Andrews, Alan D. Brown, Paul V. Fish, Alan Stobie & Florian Wakenhut. 2009. Transporters as Targets for Drugs. Transporters as Targets for Drugs
53
94
.
G. Laux, B. Bondy, U. Breyer-Pfaff, A. Delini-Stula, H. Berzewski & C. Hiemke. 2002. Neuro-Psychopharmaka Ein Therapie-Handbuch. Neuro-Psychopharmaka Ein Therapie-Handbuch
365
402
.
Carlos Corral, Jaime Lissavetzky, Ignacio Manzanares, Victoriano Darias, Marı́a A. Expósito-Orta, José A. Martı́n Conde & C.Carmen Sánchez-Mateo. (1999) Synthesis and preliminary pharmacological evaluation of thiophene analogues of viloxazine as potentialantidepressant drugs. Bioorganic & Medicinal Chemistry 7:7, pages 1349-1359.
Crossref
Crossref
Margitta Albinus, Gudrun Amschler, Uwe Amschler, Erwin von Angerer, Wolfgang Barthel, Andrea Bauer, Kurt Bauer, Jürgen Beckmann, Winfried Beil, Jürgen Beitz, Petra Berscht, Thorsten Beyrich, Katja Binder, Roswitha Böhme, Hans-Hubertus Borchert, Franz Bracher, Helmut Bräunlich, Kerstin Brinkmann, Franz von Bruchhausen, Kay Brune, Axel Büge, Wolfram Christ, Monika Cimbollek, Rolf Daniels, Gerd Dannhardt, Hans-Jürgen Duchstein, Siegfried Ebel, Kurt Eger, Peter Emig, Thomas Erker, Maria S. Fernandez-Alfonso, August Wilhelm Frahm, Margarete Frahm, Klaus-Jürgen Freundt, Detlef Geffken, Ulrich Geis, Erika Glusa, Berthold Göber, Jochen Gödicke, Margarete Goppelt-Strübe, Wilhelm Gössling, Annette Graul, Sibylle Greiner, Adolf Grisk, Michael Grosam, Markus von Gruchalla, Michael Gütschow, Axel Haberkorn, Eberhard Hackenthal, Annette Häfner, Boris Haluszczynski, Achim Harder, Sabine Hartmann, Susanne Hartmann, Dieter Heber, Gerhard Heinemeyer, Andreas Hensel, Sibylle Hoedt-Schmidt, Hermann Hoffmann, Ute Hoffmann-Schollmayer, Ulrike Holzgrabe, Martin Hug, Wolfgang Ibrom, Elisabeth Inkmann, Jens Jürgens, Brigitte Kaiser, Dieter-Abbo Kalbhen, Nasser Khudeir, Werner Kiefer, Doris Kleinsorge, Christoph Klett, Stephanie Klett, Martin Klingmüller, H.-P. Klöcking, Gerd Kobal, Axel Kramer, Mareta Kreher, Gottfried Kreutz, Reinhard Kroker, Dorothea Landsiedel-Maier, Jochen Lehmann, Marion Sylvia Lehner, Stefan Leiner, Hans Löwe, Johannes Mann, Detlef Manns, Wolfgang Matthiessen, Andreas Maurer, Wolfgang Meindl, Klaus Menges, Paul Messinger, Hans-Jürgen Mest, Frank Peter Meyer, J. Mollière, Rudolf Morgenstern, Wolfgang Morick, Joachim Mössner, Christa Müller, Daniel Müller, Klaus Müller, Walter Müller, Alexander Mülsch, Tilo Netzer, Michael Neugebauer, Ulf Niemeyer, Peter Nuhn, Bernd Nürnberg, Joachim Oertel, Michael Oettel, Hartmut Oßwald, Robert Ott, Tilmann Ott, Thomas Otzen, Peter Pachaly, Helmut Pelzer, Karl-Uwe Petersen, Martina Pickert, Andreas Pies, Klaus Pietrzik, Detlef Preiss, Helmut Priewer, Olaf Queckenberg, Eberhard Reimann, Jörg Remien, Rainer Rettig, Andreas Reymann, Joachim Richter, Hans Rommelspacher, Ulrich Rose, Gerhard Rücker, Klaus Schaefer, Helmut Schlager, Werner Schleicher, Hildegard Schleinitz, Wolfgang Schlichter, Helmut Schmidhammer, Gerhard Schmidt, Timo Schmidt, Johannes Schräder, Thomas Schulz, Gert Schulze, Peter Schwanz, Helmut Schwilden, Monika Serke, Gisela Skopp, Marcus Spohn, Ralf Stahlmann, Johannes-Peter Stasch, Christian Steffen, Jürgen Steinmeyer, Karl-Heinz Surborg, Ulf Sürig, Istvan Szelenyi, Reinhard Troschütz, Michael Verborg, Eugen J. Verspohl, Franz-Josef Volk, Heinz Walther, Horst Weber, Judith Wede, Martin Wenzel, Marion Weyandt-Spangenberg, Sandra Wich, Hilke Winterhoff, Reinhold Wintersteiger, Frauke Woltmann, Diaa Youssef & A. Ziegler. 1994. Hagers Handbuch der Pharmazeutischen Praxis. Hagers Handbuch der Pharmazeutischen Praxis
1145
1188
.
G. Laux, A. Delini-Stula, U. Breyer-Pfaff, J. Demling, D. Ebert, W. Pöldinger, S. Kasper, M. Osterheider, O. Dietmaier, H.-J. Möller & J. Fuger. 1993. Neuro-Psychopharmaka. Neuro-Psychopharmaka
105
268
.
G. Cocchiara, R. Battaglia, P. Pevarello & M. Strolin Benedetti. (1991) Comparison of the disposition and of the metabolic pattern of Reboxetine, a new antidepressant, in the rat, dog, monkey and man. European Journal of Drug Metabolism and Pharmacokinetics 16:3, pages 231-239.
Crossref
Crossref
John W. Gorrod, Catherine M. C. Whittlesea & Siu Ping Lam. 1991. Biological Reactive Intermediates IV. Biological Reactive Intermediates IV
657
664
.
Karl-Heinz BeyerKarl-Heinz Beyer. 1990. Biotransformation der Arzneimittel. Biotransformation der Arzneimittel
555
556
.
Ronald T. Coutts & Glen B. Baker. (1989) Metabolic implications of chiral centres in psychotropic drugs. Progress in Neuro-Psychopharmacology and Biological Psychiatry 13:3-4, pages 405-417.
Crossref
Crossref
Peter Crome & Sheila Dawling. 1989. Antidepressants for Elderly People. Antidepressants for Elderly People
117
136
.
R. T. Coutts & G. B. Baker. (1989) Implications of chirality and geometric isomerism in some psychoactive drugs and their metabolites. Chirality 1:2, pages 99-120.
Crossref
Crossref
Francesco Pisani, Maria C. Narbone, Antonino Fazio, Paola Crisafulli, Giuseppe Primerano, Antonina Amendola D'Agostino, Giancarla Oteri & Raoul Di Perri. (2007) Effect of Viloxazine on Serum Carbamazepine Levels in Epileptic Patients. Epilepsia 25:4, pages 482-485.
Crossref
Crossref
S. G. Al-Dabbagh & R. L. Smith. 1984. Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals. Disease, Metabolism and Reproduction in the Toxic Response to Drugs and Other Chemicals
219
231
.
A. C. Altamura, T. Melorio, G. Invernizzi, F. Colacurcio & R. Gomeni. (1983) Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications. Psychopharmacology 81:4, pages 281-285.
Crossref
Crossref
Ock Soon Sohn, Emerich S. Fiala, C.Clifford Conaway & John H. Weisburger. (1982) Metabolism and disposition of morpholine in the rat, hamster, and guinea pig. Toxicology and Applied Pharmacology 64:3, pages 486-491.
Crossref
Crossref
B. Vandel, S. Vandel, J. M. Jounet & D. Blum. (1982) Pharmacokinetics of viloxazine hydrochloride in man. European Journal of Drug Metabolism and Pharmacokinetics 7:1, pages 65-68.
Crossref
Crossref
Roberta Gillilan & William D. Masonx. (1981) High-Pressure Liquid Chromatographic Determination of Viloxazine in Human Plasma and Urine. Journal of Pharmaceutical Sciences 70:2, pages 220-221.
Crossref
Crossref
ALBERT A. KURLAND & ARRAMRAJU NAGARAJU. (2013) Viloxazine and the Depressed Schizophrenic—Methodological Issues. The Journal of Clinical Pharmacology 21:1, pages 37-41.
Crossref
Crossref
Trevor R. Norman, Graham D. Burrows, Brian M. Davies, Kay P. Maguire & Jeremy M.E. Wurm. (1980) Viloxazine plasma concentrations and clinical response. Journal of Affective Disorders 2:3, pages 157-164.
Crossref
Crossref
TR Norman, GD Burrows, BM Davies & JM Wurm. (2012) Determination of viloxazine in plasma by GLC.. British Journal of Clinical Pharmacology 8:2, pages 169-171.
Crossref
Crossref
Thomas P. Blackburn, George A. Foster, David T. Greenwood & Ralph Howe. (1978) Effects of viloxazine, its optical isomers and its major metabolites on biogenic amine uptake mechanisms in vitro and in vivo. European Journal of Pharmacology 52:3-4, pages 367-374.
Crossref
Crossref
. 1978.
21
44
.
Raghu N. Gaind & Barbara L. HudsonThomas Barnes & Robin Braithwaite. 1978. Current Themes in Psychiatry 1. Current Themes in Psychiatry 1
333
360
.
R D Brosnan, A M Busby & R P C Holland. (2016) Cases of Overdosage with Viloxazine Hydrochloride (Vivalan†). Journal of International Medical Research 4:2, pages 83-85.
Crossref
Crossref